In conclusion, our study provides evidence that certain HLA-G 3’UTR polymorphisms can influence sHLA-G levels in cancer patients’ peripheral blood, especially 14 bp Ins/Del (rs371194629) and 3142 C/G (rs1063320). This evidence concerns the gene HLA-G and cancer.